NasdaqGM - Nasdaq Real Time Price USD
Travere Therapeutics, Inc. (TVTX)
16.96
+1.08
+(6.80%)
As of 1:05:18 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
--
-237,475
-280,021
-186,291
-14,792
Investing Cash Flow
--
99,325
55,776
-32,553
-137,623
Financing Cash Flow
--
139,422
218,752
117,573
231,683
End Cash Position
--
58,535
58,176
61,688
165,753
Income Tax Paid Supplemental Data
--
--
--
--
16,420
Interest Paid Supplemental Data
--
8,838
8,838
10,159
7,327
Capital Expenditure
--
-101,212
-41,591
-28,366
-24,151
Issuance of Capital Stock
--
134,738
191,198
19,545
224,934
Issuance of Debt
--
--
--
316,250
--
Repayment of Debt
--
--
--
-211,324
--
Free Cash Flow
--
-338,687
-321,612
-214,657
-38,943
12/31/2021 - 11/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASND Ascendis Pharma A/S
158.48
-0.41%
MIRM Mirum Pharmaceuticals, Inc.
39.59
+0.41%
EWTX Edgewise Therapeutics, Inc.
14.69
+8.58%
DYN Dyne Therapeutics, Inc.
11.00
+11.00%
TRVI Trevi Therapeutics, Inc.
6.20
+2.14%
ALNY Alnylam Pharmaceuticals, Inc.
242.23
+2.31%
SWTX SpringWorks Therapeutics, Inc.
40.87
+0.91%
APLS Apellis Pharmaceuticals, Inc.
17.62
+1.44%
PTGX Protagonist Therapeutics, Inc.
46.28
+0.93%
MLTX MoonLake Immunotherapeutics
40.24
+2.00%